A Multifaceted Tech-Foward Market Leader
With a vision of becoming the most respected cannabis and CBD company in the world, our mission is to craft cutting-edge products, services, and technology driven by science and passion for the plant that customers seek and trust, while enabling communities to empower themselves.
In addition to our approved and operational state-of-the-art testing lab, our fully built, proprietary commercial-scale processing facility will soon enable use to commence oil extraction and capsule production for our own brands and CBD products, as well as third-party brands. Salvation is currently a late-stage standard processing licence applicant and is poised to receive licensing in the coming months.
Rather than operating as a fully vertically integrated firm, Salvation sees untapped potential in establishing collaborative efforts with cultivators, such as hemp farmers, First Nations, and craft growers. More than mutually beneficial partnerships, we are facilitating entirely new ecosystems that extend beyond cannabis. By not taking on cultivation in our own right, we eliminate significant risk to our bottom line while increasing the diversity of our product offering, creating even more growth opportunity. When we do what we do best and provide a space for others to thrive, we all win.
Founded in the heart of cannabis country, Nanaimo, BC, on a commitment to the production of high-quality plant based products.
Received our first SR&ED cannabis research credit (Canadian Government program for Scientific Research and Experimental Development).
Awarded dealer licence (DL) and hemp processing licence (HPL), enabling us to be one of the first in the country to operate a fully-licensed analytics laboratory, as well as buy, sell, and process hemp at a commercial scale.
Received an amendment to HPL to allow the sale and distribution of flowering heads, leaves, and branches.
Became the first company eligible to sell outdoor-grown cannabinoids for use in the regulated market.
Received Emerald Accreditation for potency and pesticide testing.
Analytical testing licence successfully transitioned to Cannabis Act.
Dealer's License received by the Office of Controlled Substances to enable testing of several psychedelics.
RTO Target Identified; TSX:V ticker symbol reserved: TSX:V SLAB
Invited to tender evidence package to Health Canada (planned for September).
As Dedicated Experts and Connoisseurs Operating One of Western Canada’s Most Trusted Independent Testing Labs, We Pride Ourselves on:
We’re proud of our team of acclaimed scientists and PhDs, who have spearheaded research and development while creating analytical methods and processes that exceed industry standards.
Being located in the heart of the world’s best source for cannabis strains and know-how allows us to harness the best expertise from the craft market. Our industry-leading team understands the cannabis customer and marketplace, and brings ample formulation and extraction experience to the table.
Proprietary methods, equipment, and technology allow for efficient end-to-end operational execution that utilizes low-cost by-product to produce standardized, high-quality and high-margin output.
Four different licences will result in multiple revenue streams: Analytical testing licence, hemp processing licence (HPL), standard processing licence (late-stage applicant, currently under review), and dealer’s licence under the Controlled Drugs and Substances Act (licence for psilocybin and other substances).
Symbiotic partnerships with hemp farmers, First Nations, craft growers, and social enterprises such as Numinus open up new opportunities while minimizing risk.
Our collaborative structure respects divergent backgrounds and allows our teams to work in concert, capitalizing on several streams of the market. Each facet of our operation in turn feeds and benefits the others in a truly symbiotic ecosystem.